
Our latest study by Dr. Ralf Kleef et al, 2020 published in Cancer Immunology, Immunotherapy journal
We are proudly announcing that our latest and most important publication by Dr. Ralf Kleef et al, 2020 Low‑dose ipilimumab plus nivolumab combined with IL‑2 and hyperthermia in cancer patients […]